BioWin is launching the 30th Competitive Cluster call for R&I projects Submit your letter of intent until January 27, 2020 BioWin is launching the 30th Competitive Cluster call for R&I projects. Letters of Intent can be submitted until January 27, 2020. If you have any question, please contact the R&I department ! Documents (only…
Bioxodes announces the initiation of a double blind, placebo controlled, single ascending dose phase I trial Bioxodes announces on October, 15 obtaining the authorization to launch phase I trial of its antithrombotic drug, Ir-CPI, in healthy male volunteers Ir-CPI is a potential best-in-class antithrombotic drug having an innovative mechanism of action (coagulation factors XIIa/XIa inhibition) to reduce…
Business Village Ecolys
Avenue d’Ecolys 2
5020 Namur (Belgium)
Email : contact@biowin.org
VAT BE 0882.768.591
Website by Monkeys not Donkeys
© 2024 BioWin.
